Renaissance Technologies (RenTech)'s FHTX Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 377,936 shares of Foghorn Therapeutics Inc. (FHTX) worth $1.84 M, representing 0.00% of the portfolio. First purchased in 2024-Q2, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in FHTX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 179,500 shares. Largest reduction occurred in Q2 2026, reducing 28,489 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Foghorn Therapeutics (FHTX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Foghorn Therapeutics (FHTX) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -28,489 | Reduce 7.01% | 377,936 | $4.88 |
| Q1 2026 | +108,689 | Add 36.51% | 406,425 | $4.78 |
| Q4 2025 | +179,500 | Add 151.82% | 297,736 | $5.40 |
| Q3 2025 | +55,600 | Add 88.77% | 118,236 | $4.89 |
| Q2 2025 | +5,400 | Add 9.43% | 62,636 | $4.70 |
| Q1 2025 | +9,500 | Add 19.90% | 57,236 | $3.65 |
| Q4 2024 | +22,500 | Add 89.16% | 47,736 | $4.72 |
| Q3 2024 | +14,536 | Add 135.85% | 25,236 | $9.31 |
| Q2 2024 | +10,700 | New Buy | 10,700 | $5.75 |
Renaissance Technologies (RenTech)'s Foghorn Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Foghorn Therapeutics Inc. (FHTX) in Q2 2024, acquiring 10,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Foghorn Therapeutics Inc. (FHTX) for 9 quarters since Q2 2024.
Renaissance Technologies (RenTech)'s largest addition to Foghorn Therapeutics Inc. (FHTX) was in Q4 2025, adding 297,736 shares worth $1.61 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 377,936 shares of Foghorn Therapeutics Inc. (FHTX), valued at approximately $1.84 M.
As of the Q2 2026 filing, Foghorn Therapeutics Inc. (FHTX) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Foghorn Therapeutics Inc. (FHTX) was 406,425 shares, as reported at the end of Q1 2026.